---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-261722"
form_type: "8-K"
ticker: "CRBP"
cik: "0001595097"
company_name: "Corbus Pharmaceuticals Holdings, Inc."
filed_at: "2025-11-03T23:59:59+00:00"
generated_at: "2026-05-17T00:52:58.831645+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Corbus Pharmaceuticals prices $75M public offering of common stock and warrants

## Summary
- Offering of 4,744,231 shares at $13.00/share and 1,025,000 pre-funded warrants at $12.9999 each for ~$75M gross proceeds.
- Net proceeds to Corbus expected ~$70.5M; underwriters have 30-day option for additional 865,384 shares.
- Proceeds to fund clinical pipeline development and general corporate purposes.
- Pre-funded warrants exercisable immediately at $0.0001/share, capped at 9.99% beneficial ownership.
- Jefferies leads underwriting; RBC, LifeSci Capital, Mizuho as lead managers.

## SEC filing metadata
- accession: 0001193125-25-261722
- form_type: 8-K
- ticker: CRBP
- cik: 0001595097
- company_name: Corbus Pharmaceuticals Holdings, Inc.
- filed_at: 2025-11-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595097/000119312525261722/0001193125-25-261722-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595097/000119312525261722/crbp-20251030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-261722
- JSON: https://secwatch.observer/filing/0001193125-25-261722.json
- Plain text: https://secwatch.observer/filing/0001193125-25-261722.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.